Amy Pitzer, DPM
Primary Podiatric Medicine · Greenville, NCNPI 1497927339
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 285 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,072 and has fallen 72.5% since, to $570 in 2025.
Across 285 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- Smith+Nephew$1K
- Imbed Biosciences Inc.$606
- Convatec Inc.$485
- Johnson & Johnson$384
- Amgen$375
- plus $3K from 35 others
What the payments were for
- Food & beverage$6,615100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 48 | $1,218 |
| Smith+Nephew | 52 | $1,053 |
| Imbed Biosciences Inc. | 22 | $606 |
| Convatec Inc. | 13 | $485 |
| Johnson & Johnson(3 entities) | 4 | $384 |
| Amgen(2 entities) | 24 | $375 |
| Triad Life Sciences Inc. | 10 | $343 |
| Paratek Pharmaceuticals, Inc. | 19 | $294 |
| Epsfl, LLC | 2 | $255 |
| Nevro Corp. | 6 | $204 |
| Tricoast Surgical Solutions LLC | 2 | $147 |
| Ossio Inc | 1 | $120 |
| Zyla Life Sciences, Inc. | 27 | $109 |
| Polarityte, Inc. | 4 | $103 |
| AbbVie | 6 | $97 |
| Mimedx Group, Inc. | 3 | $72 |
| Melinta Therapeutics, LLC | 4 | $68 |
| Abbott | 2 | $46 |
| Zimmer Biomet | 3 | $44 |
| Globus Medical | 2 | $44 |
| Merck | 3 | $44 |
| Paragon 28, Inc. | 1 | $41 |
| Urgo Medical North America, LLC | 2 | $35 |
| Bioventus LLC | 2 | $34 |
| Solventum Corporation | 2 | $33 |
| Hydrofera LLC | 2 | $31 |
| Acell, Inc. | 1 | $30 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Averitas Pharma Inc. | 1 | $26 |
| Next Science LLC | 2 | $25 |
| Kerecis Limited | 2 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Davol Inc. | 1 | $24 |
| Biocomposites Inc | 1 | $24 |
| Vertex | 1 | $23 |
| GRT US Holding, Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Sebela Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$250
- Stravix$144
- Senza$139
- MOTOBAND$118
- Vivigen MIS Delivery System$118
- MINIBUNION$118
How this compares
$6,621 in reported general payments places this provider in the 85th percentile of 64 primary podiatric medicine providers in North Carolina.
See all primary podiatric medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Febuxostat | 40 | $2,674 |
| Ketoconazole | 144 | $2,655 |
| Pregabalin | 61 | $1,671 |
| Mupirocin | 188 | $1,506 |
| Gentamicin Sulfate | 41 | $1,185 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 12 | $1,037 |
| CiclopiroxCiclopirox Olamine | 40 | $962 |
| Gabapentin | 75 | $805 |
| Halobetasol Propionate | 14 | $683 |
| Allopurinol | 60 | $547 |
| Celecoxib | 19 | $539 |
| Colchicine | 12 | $538 |
| Ciclopirox | 13 | $466 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 43 | $447 |
| Doxycycline Hyclate | 27 | $349 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Greenville
- Jon StancilGreenville$9K
- Ashma DavidsonStatesville$32K
- Joseph KiblerSupply$23K
- Jacob PaniciCary$13K
- Ythan WebsterNew Bern$10K
- Kevin McDonaldConcord$8K
- Eric WardMatthews$7K
- Clark BrackneyGreensboro$7K
- Rose SoutherlandWilmington$5K
- John LordDurham$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.